Lung lining fluid glutathione attenuates IL-13-induced asthma

Area of Science:

• Biochemistry
• Immunology
• Pulmonology

Background:

• Gamma-glutamyl transferase (GGT) deficiency leads to intracellular glutathione depletion and oxidative stress.
• Altered glutathione metabolism's role in bronchial asthma pathogenesis remains unclear.

Purpose of the Study:

• To investigate the impact of modified glutathione metabolism on airway inflammation and asthma development.
• To explore the protective role of extracellular glutathione in the lung lining fluid.

Main Methods:

• Induction of airway inflammation and asthma using intratracheal IL-13 in wild-type (WT) and GGT-deficient (GGT(enu1)) mice.
• Assessment of lung inflammation, airway epithelial cell responses (mucous cell hyperplasia, mucin expression), epidermal growth factor receptor (EGFR) activation, and airway hyperreactivity.
• Pharmacological inhibition of GGT in WT mice.

Main Results:

• Both WT and GGT(enu1) mice exhibited similar lung inflammation levels.
• IL-13 induced asthma-related features (mucous cell hyperplasia, mucin expression, EGFR activation, airway hyperreactivity) in WT mice but not in GGT(enu1) mice.
• GGT(enu1) mice had 10-fold higher extracellular glutathione in lung lining fluid, offering enhanced protection against reactive oxygen species.

Conclusions:

• Extracellular glutathione in lung lining fluid protects against IL-13-induced asthma.
• Inhibiting GGT activity in the lung lining fluid may represent a novel therapeutic approach for asthma.
• Targeting GGT offers a potential strategy for asthma prevention and treatment.